Bromocriptine Mesylate (Generic for Parlodel)

Introducing Bromocriptine Mesylate developed to the Parlodel standard—a dopamine agonist that activates D2 receptors to improve motor control and reduce Parkinson’s symptoms. This formulation enhances dopamine transmission while minimizing motor fluctuations, resulting in smoother movements and reduced rigidity for effective symptom management.